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BACKGROUND: Nutritional support is crucial to the management of patients
receiving invasive mechanical ventilation (IMV) and the most commonly prescribed
treatment in intensive care units (ICUs). International guidelines consistently indicate
that enteral nutrition (EN) should be preferred over parenteral nutrition (PN)
whenever possible and started as early as possible. However, no adequately designed
study has evaluated whether a specific nutritional modality is associated with
decreased mortality. The primary goal of this trial is to assess the hypothesis that
early first-line EN, as compared to early first-line PN, decreases day 28 all-cause
mortality in patients receiving IMV and vasoactive drugs for shock.
METHODS/DESIGN: The NUTRIREA-2 study is a multicenter, open-label, parallel-
group, randomized controlled trial comparing early PN versus early EN in critically ill
patients requiring IMV for an expected duration of at least 48 hours, combined with
vasoactive drugs, for shock. Patients will be allocated at random to first-line PN for at
least 72 hours or to first-line EN. In both groups, nutritional support will be started
within 24 hours after IMV initiation. Calorie targets will be 20 to 25 kcal/kg/day
during the first week, then 25 to 30 kcal/kg/day thereafter. Patients receiving PN may
be switched to EN after at least 72 hours in the event of shock resolution (no
vasoactive drugs for 24 consecutive hours and arterial lactic acid level below 2
mmol/L). On day 7, all patients receiving PN and having no contraindications to EN
will be switched to EN. In both groups, supplemental PN may be added to EN after
day 7 in patients with persistent intolerance to EN and inadequate calorie intake. We
plan to recruit 2,854 patients at 44 participating ICUs. DISCUSSION: The
NUTRIREA-2 study is the first large randomized controlled trial designed to assess
the hypothesis that early EN improves survival compared to early PN in ICU patients.
Enrollment started on 22 March 2013 and is expected to end in November 2015.
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